JPMorgan: "We remain cautious on shares of Underweight-rated TSLA."
Price target: $200
Rating: Underweight
"We remain cautious on shares of Underweight-rated TSLA on lofty valuation coupled with high investor expectations, high execution risk, and the potential for a pending cut to full-year delivery guidance at the time of 3Q earnings," JPMorgan analysts wrote in a note to clients on October 18.
Wedbush: "We continue to believe the biggest overhang around the story is the ability to hit profitability."
Price target: $220
Rating: Neutral
"We continue to believe the biggest overhang around the story is the ability to hit profitability and achieve its ambitious unit guidance for 2019 of 360k to 400k units," Wedbush analyst Daniel Ives wrote in a note to clients on October 18.
Ives continued: "Balancing the ability to hit these goals with a profitable business model remains the crux of the story for Tesla as gross margins (driving 20%+ GM key) need to tick up despite selling a markedly lower priced Model 3 vehicle going forward."
Roth Capital: "Tesla's weak 3Q19 is already telegraphed."
Price target: $224
Rating: Neutral
"The 3Q19 deliveries number was a miss, so we think investors need to carefully analyze pressures causing weakness," Roth Capital analysts wrote in a note to clients on October 22.
They added: "Tesla's weak 3Q19 is already telegraphed. With the 97k deliveries in the quarter, below our 105k estimate, both revenue and EPS should be light."
Macquarie: "With some seasonal tailwinds, we believe achieving the lower end of its 360-400k for the year as feasible."
Price target: $400
Rating: Outperform
"With some seasonal tailwinds, we believe achieving the lower end of its 360-400k for the year as feasible," Macquarie analysts wrote in a note to clients on October 22.
The analyst added: "We will look for an update on the feasibility of Mr. Musk's 2,000 unit/week production target for 2019 year end. In addition, we will watch for any indication of a potential pull forward of Model Y launch in 2020."